Stock Taper
EARNINGS CALL ARCHIVE 2 CALLS ON FILE
SMMT — Summit Therapeutics Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

FEB 24, 2026
REVENUE
$0
EPS
-$0.29 +6.5%
FREE CASH FLOW
-$75.8M -9.4%

No summary has been written for this call yet.